↓ Skip to main content

RANKL synthesized by articular chondrocytes contributes to juxta-articular bone loss in chronic arthritis

Overview of attention for article published in Arthritis Research & Therapy, June 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

twitter
5 X users

Citations

dimensions_citation
50 Dimensions

Readers on

mendeley
69 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
RANKL synthesized by articular chondrocytes contributes to juxta-articular bone loss in chronic arthritis
Published in
Arthritis Research & Therapy, June 2012
DOI 10.1186/ar3884
Pubmed ID
Authors

Maria J Martínez-Calatrava, Ivan Prieto-Potín, Jorge A Roman-Blas, Lidia Tardio, Raquel Largo, Gabriel Herrero-Beaumont

Abstract

The receptor activator nuclear factor-kappaB ligand (RANKL) diffuses from articular cartilage to subchondral bone. However, the role of chondrocyte-synthesized RANKL in rheumatoid arthritis-associated juxta-articular bone loss has not yet been explored. This study aimed to determine whether RANKL produced by chondrocytes induces osteoclastogenesis and juxta-articular bone loss associated with chronic arthritis.

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 69 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 2 3%
Greece 1 1%
Sweden 1 1%
Russia 1 1%
Unknown 64 93%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 12 17%
Student > Master 11 16%
Researcher 11 16%
Student > Bachelor 9 13%
Student > Doctoral Student 7 10%
Other 9 13%
Unknown 10 14%
Readers by discipline Count As %
Medicine and Dentistry 18 26%
Agricultural and Biological Sciences 16 23%
Biochemistry, Genetics and Molecular Biology 9 13%
Immunology and Microbiology 4 6%
Pharmacology, Toxicology and Pharmaceutical Science 3 4%
Other 5 7%
Unknown 14 20%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 June 2012.
All research outputs
#8,535,472
of 25,374,647 outputs
Outputs from Arthritis Research & Therapy
#1,710
of 3,381 outputs
Outputs of similar age
#60,040
of 177,865 outputs
Outputs of similar age from Arthritis Research & Therapy
#30
of 69 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,381 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.2. This one is in the 38th percentile – i.e., 38% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 177,865 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 69 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.